Gerhard Mayr - UCB SA Insider

UCB SA -- USA Stock  

USD 40.14  1.26  3.24%

Non-Executive Chairman of the Board

Mr. Gerhard N. Mayr has served as NonExecutive Chairman of the Board of U C B S.A. since May 2012. He served as NonExecutive Independent Director of the Company between June 14, 2005 and May 2012. He received a Master degree in Chemical Engineering from the Swiss Federal Institute of Technology in 1969, and a MBA degree from Stanford University in 1972. In March 2004, he retired as Executive Vice President of pharmaceutical operations at Eli Lilly Company after 32 years of service
Age: 68  Chairman Since 2012      
32 2 559 99 99  http://www.ucb.com
Mayr is Member of the Board of Lonza Group Ltd ., Member of the Board of the Vienna Science, Research and Technology Foundation and Member of the Board of Project Hope, United States . He is Member of the circle of patrons of INSEAD Business School . He was previously Member of the board of Alcon, Inc

Management Efficiency

The company has return on total asset (ROA) of 6.67 % which means that it generated profit of $6.67 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 13.73 % meaning that it generated $13.73 on every $100 dollars invested by stockholders.
The company has accumulated 1.93 B in total debt with debt to equity ratio (D/E) of 27.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. UCB SA has Current Ratio of 1.34 which is within standard range for the sector.

Similar Executives

Found 9 records

CHAIRMAN Since

Jose SierraIndustria de Diseo Textil S A
2012
Santiago TrujilloInterconexin Elctrica S A E S P
2016
Lirong XuChina Merchants Bank Co Ltd
2016
Jianhong LiChina Merchants Bank Co Ltd
2014
Moncef SlaouiGlaxoSmithKline plc
2014
Jianbo LiChina Merchants Bank Co Ltd
2014
Ramon TunezIndustria de Diseo Textil S A
N/A
Pablo TejeraIndustria de Diseo Textil S A
2011
Zehua MaChina Merchants Bank Co Ltd
2014

Entity Summary

UCB SA, a biopharmaceutical company, focuses on the discovery and development of medicines and solutions for people living with severe diseases of the immune system or of the central nervous system. UCB SA was founded in 1928 and is based in Brussels, Belgium. UCB SA operates under Biotechnology classification in USA and traded on OTC Market. It employs 7478 people.UCB SA (UCBJY) is traded on OTC Market in USA. It is located in All?e de la Recherche, 60 and employs 7,478 people.

UCB SA Leadership Team

Pascale Richetta, President
Detlef Thielgen, CFO
Kay Davies, Director
Dirk Teuwen, VP
Anna Richo, EVP
Viviane Monges, Director
Gerhard Mayr, Chairman
Cyril Janssen, Director
Cedric Rijckevorsel, Director, CFA
JeanChristophe Tellier, Chairman
Arnoud Calesberg, Director
Mark McDade, COO
Xavier Michel, President
Dhavalkumar Patel, President
Bharat Tewarie, President, MBA
Roch Doliveux, Chairman
Norman Ornstein, Director
Jeff Wren, President
JeanPierre Kinet, Director, Ph.D
Antje Witte, VP
Alice Dautry, Director
Harriet Edelman, Director, MBA
Ulf Wiinberg, Director
Thomas McKillop, Director, Ph.D
Charl Zyl, President
France Nivelle, VP
Fabrice Enderlin, President
Pierre Gurdjian, Director
Ismail Kola, EVP, Ph.D
Emmanuel Caeymaex, President
Evelyn Bergendal, Executive
Iris LoewFriedrich, President, Ph.D
CharlesAntoine Janssen, Director
Albrecht Graeve, Director
JeanLuc Fleurial, President
Alexander Moscho, President

Stock Performance Indicators

Did you try this?

Run Financial Widgets Now
   

Financial Widgets

Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
View All  Next Launch Financial Widgets

Trending Equities

Currently Active Assets on Macroaxis
F   
 NYQ 
Purchased over 200 shares of
a day ago
Traded for 10.96
MSFT   
 NMS 
Purchased over 30 shares of
a day ago
Traded for 96.11
GM   
 NYQ 
Purchased over 70 shares of
a day ago
Traded for 37.77
DD   
 NYQ 
Purchased over 100 shares of
a day ago
Traded for 30.6
CRM   
 NYQ 
Purchased over 20 shares of
a day ago
Traded for 124.06
RKDA   
 NCM 
Purchased over 100 shares of
a day ago
Traded for 23.82
Also please take a look at World Market Map. Please also try Fundamentals Matrix module to view fundamentals matrix and analyze how accounts are interrelated and interconnected with each other.